Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer
Trilaciclib剂量选择:对广泛期小细胞肺癌患者的临床前数据和Ib/IIa期研究进行综合药代动力学和药效学分析
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-021-04239-9
Li, Chao; Hart, Lowell; Owonikoko, Taofeek K; Aljumaily, Raid; Rocha Lima, Caio Max; Conkling, Paul R; Webb, Roy Timothy; Jotte, Robert M; Schuster, Steven; Edenfield, William J; Smith, Deborah A; Sale, Mark; Roberts, Patrick J; Malik, Rajesh K; Sorrentino, Jessica A